Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Rabeprazole or its salts I DEC / 13
Rabies immune globulin I FEB / 02
Rabies vaccine I FEB / 02
Racemethionine II SEP / 98
Raloxifene or its salts I DEC / 13
Raltegravir or its salts I DEC / 13
Raltitrexed or its salts or derivatives

Including but not limited to raltitrexed disodium.

I DEC / 13
Ramipril or its salts or derivatives I DEC / 13
Ramucirumab I OCT / 15
Ranibizumab I DEC / 13
Ranitidine or its salts

For human use - except when sold in concentrations of 150 mg or less per oral dosage unit and indicated for the treatment of heartburn.

I DEC / 13
Ranitidine or its salts. when sold in concentrations of 150 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing more than 4,500 mg of ranitidine III MAR / 08
Ranitidine or its salts.. when sold in concentrations of 150 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing no more than 4,500 mg of ranitidine U FEB / 07
Rasagiline or its salts I DEC / 13
Rasburicase I DEC / 13
Raubasine or its salts I DEC / 13
Rauwolfia I DEC / 13
Ravulizumab I OCT / 19
Regorafenib or its salts I DEC / 13
Remdesivir or its salts or derivatives I JUL / 20
Remestemcel-L I DEC / 13
Remoxipride or its salts I DEC / 13
Repaglinide or its salts or derivatives I DEC / 13
Rescinnamine or its salts I DEC / 13
Reserpine or its salts

For human use.

I DEC / 13
Reslizumab I JUN / 17
Resocortol or its derivativesPDL I DEC / 13
Retapamulin I DEC / 13
Reviparin or its salts I DEC / 13
Rho D immune globulin I FEB / 02
Ribavirin I DEC / 13
Ribociclib or its salts I MAY / 18
Rifabutin or its salts I DEC / 13
Rifampin or its salts or derivatives I DEC / 13
Rifaximin or its salts or derivatives I DEC / 13
Rilpivirine or its salts or derivatives

Including but not limited to rilpivirine hydrochloride.

I DEC / 13
Riluzole or its salts I DEC / 13
Riociguat or its derivatives I DEC / 13
Ripretinib or its salts I SEP / 20
Risankizumab I JUL / 19
Risedronic acid or its salts I DEC / 13
Risperidone or its salts I DEC / 13
Ritodrine and its salts I DEC / 13
Ritonavir I DEC / 13
Rituximab I DEC / 13
Rivaroxaban I DEC / 13
Rivastigmine or its salts I DEC / 13
Rizatriptan or its salts I DEC / 13
Robenacoxib or its salts I DEC / 13
Rocuronium bromide I DEC / 13
Rofecoxib I DEC / 13
Roflumilast or its salts or derivatives I DEC / 13
Romidepsin I DEC / 13
Romifidine or its salts I DEC / 13
Romiplostim I DEC / 13
Romosozumab I OCT / 19
Ronidazole or its salts or derivatives

For human use.

I DEC / 13
Ropinirole or its salts I DEC / 13
Rose Bengal II SEP / 98
Rosiglitazone or its salts I DEC / 13
Rosoxacin or its salts I DEC / 13
Rosuvastatin or its salts I DEC / 13
Rotigotine or its salts or derivatives I DEC / 13
Rubella vaccine II DEC / 98
Rue and its preparations and extracts II SEP / 98
Rufinamide or its derivatives I DEC / 13
Rupatadine or its salts I FEB / 17
Ruxolitinib or its salts

Including but not limited to ruxolitinib phosphate.

I DEC / 13

68 result(s)


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act